ZLN005 and metformin cell toxicity. by Joel R. Frandsen (20685133)

Subjects:

ZLN005 increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

Subjects:

ZLN005 and metformin toxicity in MAC. by Joel R. Frandsen (20685133)

Subjects:

Full Western blot images from manuscript. by Joel R. Frandsen (20685133)

Subjects:

Metformin rescues PGC-1α expression in presence of inhibitor. by Joel R. Frandsen (20685133)

Subjects:

Metformin increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

Subjects:

Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α. by Joel R. Frandsen (20685133)

Subjects:

Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. by Joel R. Frandsen (20685133)

Subjects:

Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

Subjects:

NTM infection induces mitochondrial damage and reduces mitochondria number. by Joel R. Frandsen (20685133)

Subjects:

Cerium Oxide Nanoparticle Protects Maize from Cobalt Stress: Insights from Transcriptomics and Oxidative Stress Response Analysis by Abdul Salam (3494279)

“…Additionally, RNA-Seq analysis revealed significant alterations in the expression of key genes related to ion binding, metal transporters, and metabolite biosynthesis, offering molecular evidence of their role under Co stress. …”

Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

Subjects:

Common DEGs between Antonio and Colorado after MCP application under control condition. by Wardah K. Mustahsan (17484456)

Subjects:

Effect of variety on physiological traits under ambient night-time temperature (ANT) and high night-time temperature (HNT) conditions, with or without MCP (1-methylcyclopropene) tr... by Wardah K. Mustahsan (17484456)

Subjects:

Venn diagrams of the number of DEGs between each comparison. by Wardah K. Mustahsan (17484456)

Subjects:

Age-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Average proportion of first choice female applicants stratified by specialty category. by Lucy Hui (17538542)

Subjects:

Temporal Trends and Forecasting of Hand, Foot, and Mouth Disease. by Haipeng Luo (5322419)

Subjects:

Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

Subjects: